Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Poster display session

2569 - Incidence and outcome of Incidental Pulmonary Embolism (IPE) in oncology patients with current macroscopic disease


10 Sep 2017


Poster display session


Supportive Care and Symptom Management


Maung Maung Myat Moe


Annals of Oncology (2017) 28 (suppl_5): v543-v567. 10.1093/annonc/mdx388


M.M.M. Moe

Author affiliations

  • Oncology, Yeovil District Hospital, BA214AT - Yeovil/GB


Abstract 2569


IPE is defined as a PE detected on a CT scan (not a pulmonary angiogram) done for reasons other than suspected PE. This study is to evaluate the incidence of IPE in oncology patients with current macroscopic disease, and the outcome that could potentially be affected by a delay in starting anticoagulation therapy due to delayed reporting of these routine (non-urgent) scans.


CT thorax with iv contrast done on oncology patients between 01.01.15 – 31.12.15 in two district general hospitals in a cancer network were identified from the database. The scan reports and clinic letters were reviewed for data on cancer diagnosis, macroscopic disease, PE, treatments and survivals.


2147 scans were identified. 543 scans were excluded due to absence of macroscopic disease (No IPE was reported in any of these scans.) leaving 1604 scans eligible for this study. Incidence for different tumour is shown in the table 1. 26 IPE patients are female = 15; median age = 66 (range 32 – 90); main artery = 9; lobar artery = 5; average time from CT scan to anticoagulation (LMWH) therapy is 9.7 days (median = 5 days; range = 0 – 61 days; no treatment in 3 patients) mainly due to the delay in reporting (median = 1 day; range = 0 – 60 days). The median survival from the scan date is 7 months (range = 1 – 22) with 9 patients still alive and 2 lost to follow up. None of the patients whose anticoagulation started 5 or more days after the CT scan died within 3 months. IPE was absent in all subsequent CT scans. This happened without any anticoagulation therapy in one patient who had a segmental IPE. Table 1. Incidence of IPE for different tumour typesrnTable:


PatientsScansScans with IPE (% of total scans)
Lung2355879 (1.5%)
Breast1482675 (1.9%)
Colorectal1423105 (1.6%)
Oeso/gastric721632 (1.2%)
Mesothelioma8191 (5.3%)
CUP15301 (3.3%)
Bladder15311 (3.2%)
NET111 (100%)
Prostate41871 (1.2%)
H & N8180
Total731160426 (1.6%)


Incidence of IPE in oncology patients with current macroscopic disease is low (1.6%) in daily practice. Most patients are likely to have lung, breast and colorectal cancers. This is probably due to the fact that these are common tumours, and the frequency of scanning in their management. No sudden death or mortality within 30 days was noted among patients who had anticoagulation therapy started 5 or more days after the CT scan. Spontaneous resolution of PE happened in one patient with segmental PE. More research is needed to select patients who may not get any meaningful benefit from anticoagulation in the presence of advanced malignant disease.

Clinical trial identification


Legal entity responsible for the study

Maung Maung Myat Moe




All authors have declared no conflicts of interest.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.